Cargando…

All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes

OBJECTIVE: This study assessed all-cause and specific-cause mortality after Roux-en-Y gastric bypass (RYGB) and in matched control subjects, stratified by diabetes status. RESEARCH DESIGN AND METHODS: RYGB patients were matched by age, BMI, sex, and diabetes status at time of surgery to nonsurgical...

Descripción completa

Detalles Bibliográficos
Autores principales: Lent, Michelle R., Benotti, Peter N., Mirshahi, Tooraj, Gerhard, Glenn S., Strodel, William E., Petrick, Anthony T., Gabrielsen, Jon D., Rolston, David D., Still, Christopher D., Hirsch, Annemarie G., Zubair, Fahad, Cook, Adam, Carey, David J., Wood, G. Craig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606311/
https://www.ncbi.nlm.nih.gov/pubmed/28760742
http://dx.doi.org/10.2337/dc17-0519
_version_ 1783265126404587520
author Lent, Michelle R.
Benotti, Peter N.
Mirshahi, Tooraj
Gerhard, Glenn S.
Strodel, William E.
Petrick, Anthony T.
Gabrielsen, Jon D.
Rolston, David D.
Still, Christopher D.
Hirsch, Annemarie G.
Zubair, Fahad
Cook, Adam
Carey, David J.
Wood, G. Craig
author_facet Lent, Michelle R.
Benotti, Peter N.
Mirshahi, Tooraj
Gerhard, Glenn S.
Strodel, William E.
Petrick, Anthony T.
Gabrielsen, Jon D.
Rolston, David D.
Still, Christopher D.
Hirsch, Annemarie G.
Zubair, Fahad
Cook, Adam
Carey, David J.
Wood, G. Craig
author_sort Lent, Michelle R.
collection PubMed
description OBJECTIVE: This study assessed all-cause and specific-cause mortality after Roux-en-Y gastric bypass (RYGB) and in matched control subjects, stratified by diabetes status. RESEARCH DESIGN AND METHODS: RYGB patients were matched by age, BMI, sex, and diabetes status at time of surgery to nonsurgical control subjects using data from the electronic health record. Kaplan-Meier curves and Cox regression were used to assess differences in all-cause and specific-cause mortality between RYGB patients and control subjects with and without diabetes. RESULTS: Of the 3,242 eligible RYGB patients enrolled from January 2004 to December 2015, control subjects were identified for 2,428 (n = 625 with diabetes and n = 1,803 without diabetes). Median postoperative follow-up was 5.8 years for patients with diabetes and 6.7 years for patients without diabetes. All-cause mortality was reduced in RYGB patients compared with control subjects only for those with diabetes at the time of surgery (adjusted hazard ratio 0.44; P < 0.0001). Mortality was not significantly improved in RYGB patients without diabetes compared with control subjects without diabetes (adjusted hazard ratio 0.84; P = 0.37). Deaths from cardiovascular diseases (P = 0.011), respiratory conditions (P = 0.017), and diabetes P = 0.011) were more frequent in control subjects with diabetes than in RYGB patients with diabetes. RYGB patients without diabetes were less likely to die of cancer (P = 0.0038) and respiratory diseases (P = 0.046) than control subjects without diabetes but were at higher risk of death from external causes (P = 0.012), including intentional self-harm (P = 0.025), than control subjects without diabetes. CONCLUSIONS: All-cause mortality benefits of RYGB are driven predominantly by patients with diabetes at the time of surgery. RYGB patients with diabetes were less likely to die of cardiovascular diseases, diabetes, and respiratory conditions than their counterparts without RYGB.
format Online
Article
Text
id pubmed-5606311
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-56063112018-10-01 All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes Lent, Michelle R. Benotti, Peter N. Mirshahi, Tooraj Gerhard, Glenn S. Strodel, William E. Petrick, Anthony T. Gabrielsen, Jon D. Rolston, David D. Still, Christopher D. Hirsch, Annemarie G. Zubair, Fahad Cook, Adam Carey, David J. Wood, G. Craig Diabetes Care Cardiovascular and Metabolic Risk OBJECTIVE: This study assessed all-cause and specific-cause mortality after Roux-en-Y gastric bypass (RYGB) and in matched control subjects, stratified by diabetes status. RESEARCH DESIGN AND METHODS: RYGB patients were matched by age, BMI, sex, and diabetes status at time of surgery to nonsurgical control subjects using data from the electronic health record. Kaplan-Meier curves and Cox regression were used to assess differences in all-cause and specific-cause mortality between RYGB patients and control subjects with and without diabetes. RESULTS: Of the 3,242 eligible RYGB patients enrolled from January 2004 to December 2015, control subjects were identified for 2,428 (n = 625 with diabetes and n = 1,803 without diabetes). Median postoperative follow-up was 5.8 years for patients with diabetes and 6.7 years for patients without diabetes. All-cause mortality was reduced in RYGB patients compared with control subjects only for those with diabetes at the time of surgery (adjusted hazard ratio 0.44; P < 0.0001). Mortality was not significantly improved in RYGB patients without diabetes compared with control subjects without diabetes (adjusted hazard ratio 0.84; P = 0.37). Deaths from cardiovascular diseases (P = 0.011), respiratory conditions (P = 0.017), and diabetes P = 0.011) were more frequent in control subjects with diabetes than in RYGB patients with diabetes. RYGB patients without diabetes were less likely to die of cancer (P = 0.0038) and respiratory diseases (P = 0.046) than control subjects without diabetes but were at higher risk of death from external causes (P = 0.012), including intentional self-harm (P = 0.025), than control subjects without diabetes. CONCLUSIONS: All-cause mortality benefits of RYGB are driven predominantly by patients with diabetes at the time of surgery. RYGB patients with diabetes were less likely to die of cardiovascular diseases, diabetes, and respiratory conditions than their counterparts without RYGB. American Diabetes Association 2017-10 2017-07-31 /pmc/articles/PMC5606311/ /pubmed/28760742 http://dx.doi.org/10.2337/dc17-0519 Text en © 2017 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
spellingShingle Cardiovascular and Metabolic Risk
Lent, Michelle R.
Benotti, Peter N.
Mirshahi, Tooraj
Gerhard, Glenn S.
Strodel, William E.
Petrick, Anthony T.
Gabrielsen, Jon D.
Rolston, David D.
Still, Christopher D.
Hirsch, Annemarie G.
Zubair, Fahad
Cook, Adam
Carey, David J.
Wood, G. Craig
All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes
title All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes
title_full All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes
title_fullStr All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes
title_full_unstemmed All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes
title_short All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes
title_sort all-cause and specific-cause mortality risk after roux-en-y gastric bypass in patients with and without diabetes
topic Cardiovascular and Metabolic Risk
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606311/
https://www.ncbi.nlm.nih.gov/pubmed/28760742
http://dx.doi.org/10.2337/dc17-0519
work_keys_str_mv AT lentmicheller allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes
AT benottipetern allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes
AT mirshahitooraj allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes
AT gerhardglenns allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes
AT strodelwilliame allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes
AT petrickanthonyt allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes
AT gabrielsenjond allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes
AT rolstondavidd allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes
AT stillchristopherd allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes
AT hirschannemarieg allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes
AT zubairfahad allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes
AT cookadam allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes
AT careydavidj allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes
AT woodgcraig allcauseandspecificcausemortalityriskafterrouxenygastricbypassinpatientswithandwithoutdiabetes